TREM2 is associated with advanced stages and inferior prognosis in oral squamous cell carcinoma
Triggering receptor expressed on myeloid cells 2 (TREM2) is suggested to hamper antitumor immune response in multiple cancers. However, the role of TREM2 in oral squamous cell carcinoma (OSCC) and its expression in tumor-associated macrophages (TAMs) are unknown. In this study, TREM2 expression was...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
24 September 2022
|
| In: |
Cancers
Year: 2022, Jahrgang: 14, Heft: 19, Pages: 1-14 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers14194635 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers14194635 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/14/19/4635 |
| Verfasserangaben: | Ann-Kristin Struckmeier, Anne Radermacher, Michael Fehrenz, Dalia Alansary, Philipp Wartenberg, Mathias Wagner, Anja Scheller, Jochen Hess, Julius Moratin, Christian Freudlsperger, Jürgen Hoffmann, Lorenz Thurner, Klaus Roemer, Kolja Freier and Dominik Horn |